Intology tests Locus on molecular prediction and antibody design
Its reported matched-compute comparisons favor Locus over selected baselines and AI agents, with detail on property prediction.
TLDR
Intology tested Locus on molecular property prediction, Boltz-2 potency prediction and antibody-design workflows. The company reports that Locus outperformed selected baselines and AI agents under matched compute. In its account of the property-prediction task, Locus generated nearly 1 million simulated molecule labels and met a predefined test threshold. Those performance findings are company-reported, not independently validated.
Combined views
13.7K
6 Sources, first seen ago
